Singulair, now a generic, is still used by millions of people in the United States even after thousands of patients and dozens of studies have described harm.
The research, supported by the National Institutes of Health, may reassure some patients after a European drug safety agency raised concerns last year.
A seemingly endless rotation between state forensic hospitals and city jails has meant that some mentally ill detainees stay in the system for years without ever standing trial.